Cargando…
Mutations in EPHB4 cause human venous valve aplasia
Venous valve (VV) failure causes chronic venous insufficiency, but the molecular regulation of valve development is poorly understood. A primary lymphatic anomaly, caused by mutations in the receptor tyrosine kinase EPHB4, was recently described, with these patients also presenting with venous insuf...
Autores principales: | Lyons, Oliver, Walker, James, Seet, Christopher, Ikram, Mohammed, Kuchta, Adam, Arnold, Andrew, Hernández-Vásquez, Magda, Frye, Maike, Vizcay-Barrena, Gema, Fleck, Roland A., Patel, Ashish S., Padayachee, Soundrie, Mortimer, Peter, Jeffery, Steve, Berland, Siren, Mansour, Sahar, Ostergaard, Pia, Makinen, Taija, Modarai, Bijan, Saha, Prakash, Smith, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492339/ https://www.ncbi.nlm.nih.gov/pubmed/34403370 http://dx.doi.org/10.1172/jci.insight.140952 |
Ejemplares similares
-
Human venous valve disease caused by mutations in FOXC2 and GJC2
por: Lyons, Oliver, et al.
Publicado: (2017) -
EPHB4 kinase–inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis
por: Martin-Almedina, Silvia, et al.
Publicado: (2016) -
EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity
por: Frye, Maike, et al.
Publicado: (2020) -
Angiogenesis depends upon EPHB4-mediated export of collagen IV from vascular endothelial cells
por: Chen, Di, et al.
Publicado: (2022) -
A dedicated vascular access clinic for children on haemodialysis: Two years’ experience
por: Shroff, Rukshana, et al.
Publicado: (2016)